statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Akili King has been working in the beauty world for over six years: as a columnist at Vogue and the Cut, a senior beauty editor at Rose Inc. Beauty, a writer at Milk Makeup, and, now, as the senior...

My Tiny New York Bathroom Fits 400 Products

Akili, Inc. (NASDAQ:AKLI  Get Free Report) saw a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 47,000 shares, a...

Akili, Inc. (NASDAQ:AKLI) Sees Large Drop in Short Interest

Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today reported its financial results for the quarter and full year ended December 31, 2023, and provided an update on business...

Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating...

PureTech Founded Entity Akili Announces Positive Results from Shionogis Phase 3 Clinical Trial of Localized Version of Akilis EndeavorRx for Pediatric ADHD Patients in Japan

Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that its Japanese partner Shionogi & Co. Ltd has submitted Akilis digital therapeutic SDT-001 for marketing approval...

Akili Announces Positive Results from Shionogis Phase 3 Clinical Trial of Localized Version of Akilis EndeavorRx for Pediatric ADHD Patients in Japan

Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today provided several corporate updates, including that it plans to report fourth quarter and full year 2023 financial results and a...

Akili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance Updates

Akili, Inc. (NASDAQ:AKLI  Get Free Report) was the recipient of a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 61,900...

Short Interest in Akili, Inc. (NASDAQ:AKLI) Decreases By 24.0%

Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. Its technologies are designed to directly target the physiology of the brain. The company was founded by W. Edward Martucci II and Adam Gazzaley in December 2020 and is headquartered in Boston, MA.

Volume	46,639.00
52-Wk High	$1.67
52-Wk Low	$0.1912

AKLI Akili Inc

About

Feed

News

Sentiment

Earnings

Fundamentals